SOLARIS PHARMA CORP — Form D
SOLARIS PHARMA CORP of BRIDGEWATER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-31. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-01-31
- Form: D
- Accession: 0001689748-20-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $10.0M
- Amount sold: $10.0M
- Investors: 6
- Date of first sale: 2019-12-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-359482
Issuer
- Name: SOLARIS PHARMA CORP
- CIK: 0001689748
- Entity type: Corporation
- Jurisdiction: NEW JERSEY
- Incorporated: 2014
- Address: 1031 ROUTE 202-206, SUITE G-200, BRIDGEWATER, NJ, 08807
- Phone: 908-864-0404
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Bernhard Lakshmi Hampl | Director | Bridgewater, NJ |
| Helmut Lakshmi Jeggle | Director | Bridgewater, NJ |
| Satish Lakshmi Pejaver | Director | Bridgewater, NJ |
| Manish Lakshmi Potti | Director | Bridgewater, NJ |
| Srinivas Lakshmi Raghavan | Director | Bridgewater, NJ |
| Satish Lakshmi Pejaver | Executive Officer | Bridgewater, NJ |
| Srinivas Lakshmi Raghavan | Executive Officer | Bridgewater, NJ |
| Srinivasan Lakshmi Raghavan | Director | Bridgewater, NJ |
| Srinivasan Lakshmi Raghavan | Executive Officer | Bridgewater, NJ |
Other filings by this issuer (2)
More